A B HPAF-II CFPAC-1 cells Drug concentration, µM 50

Slides:



Advertisements
Similar presentations
Supplementary Figure 1. The effect of 17-DMAG on the growth of lung cancer cells with Met amplification Tumor cells were continuously treated with increasing.
Advertisements

Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model  Jie Li, Ni Hou, Ahmad Faried, Soichi Tsutsumi,
Δ-Tocotrienol treatment is more effective against hypoxic tumor cells than normoxic cells: potential implications for cancer therapy  Akira Shibata, Kiyotaka.
A Novel Cinnamide YLT26 Induces Breast Cancer Cells Apoptosis via ROS-Mitochondrial Apoptotic Pathway in Vitro and Inhibits.
Nogo-p4 Suppresses TrkA Signaling Induced by Low Concentrations of Nerve Growth Factor Through NgR1 in Differentiated PC12 Cells Neurosignals 2016;24:25-39.
Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in.
Saikosaponin-D Enhances Radiosensitivity of Hepatoma Cells under Hypoxic Conditions by Inhibiting Hypoxia-Inducible Factor-1α Cell Physiol Biochem 2014;33:37-51.
Drug concentration (μM)
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
Figure 1. Herbacetin binds to AKT1/2 and suppresses each respective kinase activity. The effect of herbacetin on (A) PI3K/AKT and (B) MAPK signaling pathway.
Volume 18, Issue 12, Pages (December 2016)
Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer  Lanxi Song, MS, Matthew A. Smith, PhD,
Vemurafenib Induces Senescence Features in Melanoma Cells
Volume 137, Issue 3, Pages (September 2009)
Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI- 258) and its Therapeutic Implications  Shalini S. Yadav, Jinyi.
Volume 131, Issue 3, Pages (September 2006)
Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis  Dao M Nguyen, MD, Dominique.
A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils by Barbara Geering, Ursina Gurzeler, Elena Federzoni, Thomas Kaufmann,
Hyperphosphatemia induces protective autophagy in endothelial cells through the inhibition of Akt/mTOR signaling  Yu-Juei Hsu, MD, PhD, Shih-Che Hsu,
Differential effects of tumor necrosis factor-α and interleukin-1β on cell death in human articular chondrocytes  B. Caramés, Ph.D., M.J. López-Armada,
MET Tyrosine Kinase Inhibitor Crizotinib (PF ) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations 
(a) (b) SUPPLEMENTARY FIGURE 1:
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis by Yu-Tzu Tai, Mariateresa Fulciniti, Teru Hideshima, Weihua Song, Merav.
Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
Hyperphosphatemia induces protective autophagy in endothelial cells through the inhibition of Akt/mTOR signaling  Yu-Juei Hsu, MD, PhD, Shih-Che Hsu,
A Histone Deacetylase Inhibitor LBH589 Downregulates XIAP in Mesothelioma Cell Lines Which is Likely Responsible for Increased Apoptosis With TRAIL  James.
by Jun Yuan, David B. Lovejoy, and Des R. Richardson
Volume 69, Issue 8, Pages (April 2006)
Volume 44, Issue 1, Pages (January 2006)
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
FGF21 Is an Exocrine Pancreas Secretagogue
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer  Tadaaki Yamada, MD, PhD, Shinji Takeuchi,
NRP2 represses IGF-IR expression and signaling.
Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.
Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis 
Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non– Small Cell Lung Cancer Xenograft Models  Josephine Hai, PhD, Shingo Sakashita,
Volume 133, Issue 4, Pages (October 2007)
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression  Toran Sanli,
Inhibition of β-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non–small-cell Lung Cancer with a T790M Mutation  Yosuke.
S.-M. Harwood, D.-A. Allen, M.-J. Raftery, M.M. Yaqoob 
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Volume 125, Issue 1, Pages (July 2003)
Volume 137, Issue 5, Pages (November 2009)
Inhibition of β-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non–small-cell Lung Cancer with a T790M Mutation  Yosuke.
Volume 92, Issue 3, Pages (September 2017)
PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD, leading to mTORC2 activation. PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD,
Imipramine and promethazine induce the apoptotic cell death of SCLC cells through activation of caspase-3. Imipramine and promethazine induce the apoptotic.
Enhancement of receptor endocytosis, as well as cellular apoptosis, may explain the cooperative anti‐tumor actions of 3×mAbs and osimertinib Enhancement.
Molecular Therapy - Nucleic Acids
Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in xenografted mice. Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in.
Bonnie E. Lonze, Antonella Riccio, Sonia Cohen, David D. Ginty  Neuron 
Volume 8, Issue 4, Pages (October 2005)
Volume 12, Issue 4, Pages (July 2015)
Fig. 1 LB100 and LB102 specifically inhibit PP2A phosphatase activity and the growth of BCR-ABL+ cells. LB100 and LB102 specifically inhibit PP2A phosphatase.
AKT2, but not AKT1, is required for regulating survival of PTEN-deficient prostate tumor spheroids. AKT2, but not AKT1, is required for regulating survival.
Volume 18, Issue 3, Pages (March 2010)
TRAF4 is required for EGFR activation in response to EGF stimulation.
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
SEMA3C regulates prostate cancer cell growth
Therapy-induced senescence of primary cells.
Fig. 3. Effects of Tec on IL-1β-induced apoptosis in chondrocytes.
EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis  Szu-Wei Lee, Yijuan Zhang, Michael Jung, Nathalia Cruz, Basheer.
Apoptosis induced by ssHHT in HL60 and its derivative, the HL60/MRP, cells. Apoptosis induced by ssHHT in HL60 and its derivative, the HL60/MRP, cells.
Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer  Jun Young Park, Ye Lim Cho, Ju Ri Chae, Sung Hwan Moon,
PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant p53 in vivo. PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant.
Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. LNCaP,
NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.
Fig. 4 A novel peptidomimetic (AV3) against ITGA5.
DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.
Presentation transcript:

A B HPAF-II CFPAC-1 cells 0 200 400 600 800 Drug concentration, µM 50 Supplemental Figure 1 Mattheolabakis et al A HPAF-II CFPAC-1 cells 0 200 400 600 800 Drug concentration, µM 50 100 Cell growth, % control 0 200 500 600 800 Drug concentration, µM 50 100 Cell growth, % control B MIA PaCa-2 0 200 400 600 Panc-1 PA, µM ASA, µM 400 Supplemental Figure 1. Phospho-aspirin inhibits the growth of human PC cells. A: PA inhibits PC cell growth in a concentration- dependent manner. Cell growth was determined in human HPAF-II CFPAC-1 cells after treatment with escalating concentrations of PA or aspirin (ASA) for 24 h. Results are expressed as % control. B: PA inhibits colony formation in a concentration-dependent manner in MIA PaCa-2 and Panc-1 cells. Aspirin (ASA), 400 µM had no effect. Images of each condition at the end of the 7 day-period are shown.

Supplemental Figure 2 Mattheolabakis et al A Annexin V (+) cells, Fold increase over control * B Time, h 12 12 24 24 36 36 48 48 PA, 1.5xIC50 - + - + - + - + Caspase -3 Survivin β-tubilin Supplemental Figure 2. Phospho-aspirin induces apoptosis in human PC cells. A: Human Panc-1, MIA PaCa-2 or HPAF-II PC cells treated with PA 1.5xIC50 for 24 h were stained with Annexin V/propidium iodide, and the percentage of apoptotic cells was determined by flow cytometry. Results are expressed as mean ± SEM. *Significant different compared to control (p<0.01). B: PA reduces full length caspase-3 and survivin levels. Panc-1 cells were treated with PA, for various periods of time, as shown. Immunoblots for full length casepase-3, survivin. β-tubulin = loading control.

Supplemental Figure 3 Mattheolabakis et al B A Ac-p53 (K382) Ac-p53 (K379) p53 0 0.5 1 1.5 PA, xIC50 Vehicle PA Ac-p53 (K382) Vehicle PA % Ac-p53 (K382) (+) cells 10 20 30 * C Time, h 12 12 24 24 36 36 48 48 p21 β-actin PA, 1.5xIC50 - + - + - + - + Supplemental Figure 3. Phospho-aspirin induces p53 acetylation in human PC cells and xenografts. A: Effect of PA on p53 acetylation (Ac-p53) and the level of p53 in MIA PaCa-2 cells treated with PA for 2 h. B: Representative images and the quantification of Ac-p53 (K382) expression in tumor sections. The percentage of Ac-p53 positive cells in vehicle or PA-treated Panc-1 xenografts was determined by immunohistochemical staining. All values are mean ± SEM; *p<0.05, compared to vehicle control. C: Effect of PA on p21 expression in Panc-1 cells. Panc-1 cells were treated with PA, for various periods of time, as shown. Immunoblot for p21 is shown. β-actin = loading control.

PA, µM ASA, µM A23187 - + + + + + 400 600 400 600 10 20 30 PGE2, pg/ml Supplemental Figure 4 Mattheolabakis et al PA, µM ASA, µM A23187 - + + + + + 400 600 400 600 10 20 30 PGE2, pg/ml * Supplemental Figure 4: PA does not inhibit PGE2 levels in PC cells. Panc-1 cells were pretreated with various concentrations of PA or ASA for 30 min, followed by treatment with the calcium ionophore A23187 5 µM for 3 h. PGE2 levels in the culture medium were measured by enzyme- linked immunosorbent assay.

MIA PaCa-2 AsPC-1 PANC-1 HPAF-II p-EGFR (Y1045) p-EGFR (Y1068) Supplemental Figure 5 Mattheolabakis et al p-EGFR (Y992) p-EGFR (Y1045) p-EGFR (Y1068) β-actin AsPC-1 PANC-1 MIA PaCa-2 HPAF-II EGFR Supplemental Figure 5. Expression levels of phospho-EGFR (p-EGFR) in multiple human PC cells. Levels of p-EGFR expression levels at various sites was performed by WB .

B A C * MIA PaCa-2 cells AsPC-1 cells IF intensity values PA Control Supplemental Figure 6 Mattheolabakis et al A MIA PaCa-2 cells B AsPC-1 cells PA Control EGF p-EGFR Merge DAPI PA Control EGF p-EGFR Merge DAPI C IF intensity values * Supplemental Figure 6. Phospho-aspirin inhibits EGFR phosphorylation in PC cells. A-B: Phospho-aspirin (PA) inhibits EGFR phosphorylation in MIA PaCa-2 cells and AsPC-1 cells. Immunofluorescence staining for p-EGFR was performed in MIA PaCa-2 or AsPC-1 cells treated or untreatead with PA (1xIC50) for 4 h. EGF (10 ng/ml) stimulation for 15 min was used as positive control. Representative images in each group from three independent experiments are shown (original magnification, x20). The levels of p-EGFR and DAPI was observed using a Nikon ECLIPSF 90i microscope. C: Immunofluorencesce intensity in each group were quantified and results expressed as mean ± SEM. *Significant different compared to control (p<0.01).

4000 8000 12000 Amylase, U/L CTR CTR PA CTR CTR PA Cerulein 1000 2000 Supplemental Figure 7 Mattheolabakis et al 4000 8000 12000 Amylase, U/L CTR CTR PA CTR CTR PA Cerulein 3d following last cerulein injection 1h following last cerulein injection 1000 2000 3000 Lipase, U/L CTR CTR PA CTR CTR PA Cerulein 3d following last cerulein injection 1h following last cerulein injection Supplemental Figure 7. Serum amylase and lipase levels. Six week old KrasG12D mice (C57Bl/6J background) were injected intraperitoneally with saline or cerulein (250 μg/kg hourly, once per day for three consecutive days). Cerulein-injected mice were divided into vehicle control (CTR) or PA-treated groups (n=5/group). PA 100 mg/kg was given orally once a day, starting on the day of the first cerulein injection (See Fig 4A). One hour or three days after the last cerulein injection, mice were euthanized and serum was collected. Amylase and lipase levels were determined by a commercial laboratory (Antech Diagnostics).

Supplemental Figure 8 Mattheolabakis et al day 0 day 5 Supplemental Figure 8. Representative images of acinar cells explants at the time of plating (day 0) and of the resulting metaplasia (day 5) after five days of incubation. (x40)